Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023-2024

PubMed

Insights

Human myxovirus resistance protein 1 (MxA) inhibits avian influenza A(H5N1) virus replication. However, H5N1 can evade MxA restriction by acquiring specific viral components from resistant strains.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Highly pathogenic avian influenza A(H5N1) viruses pose a significant threat to public health.
  • Human myxovirus resistance protein 1 (MxA) is a key innate immune factor known to restrict viral replication.

Purpose of the Study:

  • To investigate the antiviral activity of human MxA against avian influenza A(H5N1) viruses.
  • To elucidate the mechanisms by which H5N1 viruses may evade MxA-mediated restriction.

Main Methods:

  • In vitro replication assays using H5N1 isolates and MxA-expressing cells.
  • In vivo studies utilizing MxA-transgenic mouse models.
  • Analysis of viral polymerase complex component exchange.

Main Results:

  • Human MxA demonstrably suppressed the replication of H5N1 viruses in both cell culture and transgenic mice.
  • H5N1 viruses exhibited the ability to evade MxA restriction.
  • Evading MxA involved the acquisition of specific viral polymerase components from a human-adapted, MxA-resistant strain.

Conclusions:

  • Human MxA is an effective antiviral factor against H5N1 influenza A viruses.
  • Avian influenza A(H5N1) viruses possess mechanisms to overcome MxA-mediated innate immunity.
  • Understanding viral evasion strategies is crucial for developing effective antiviral therapies against influenza.